GlySure Ltd.

Company Changes AGRAWAL , Amit To: Bellerophon Therapeutics Inc. , COO (July) From: Amgen Inc., Dir., Strategy & Corp. Dev. Phone: 908-574-4770 ARMOUR , Alison A., MD To: Endocyte Inc. , C

New At The Helm Company Changes AGRAWAL , Amit To: Bellerophon Therapeutics Inc. , COO (July) From: Amgen Inc., Dir., Strategy & Corp. Dev. Phone: 908-574-4770 ARMOUR , Alison A., MD To: En

Wherever you side in the contentious debate about the Affordable Care Act, there are aspects of it upon which everyone ought to agree. It uses financial incentives to encourage hospitals to adopt pati

HeartWare augments destination therapy trial FDA has approved an IDE supplement to allow HeartWare International Inc. to enroll additional patients in the ENDURANCE trial of the HVAD ventric